These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 12954143

  • 1. Pancreatic Enzyme Supplementation Therapy.
    Keller J, Layer P.
    Curr Treat Options Gastroenterol; 2003 Oct; 6(5):369-374. PubMed ID: 12954143
    [Abstract] [Full Text] [Related]

  • 2. Pancreatic enzyme replacement therapy.
    Layer P, Keller J, Lankisch PG.
    Curr Gastroenterol Rep; 2001 Apr; 3(2):101-8. PubMed ID: 11276376
    [Abstract] [Full Text] [Related]

  • 3. Pancreatic enzymes: secretion and luminal nutrient digestion in health and disease.
    Layer P, Keller J.
    J Clin Gastroenterol; 1999 Jan; 28(1):3-10. PubMed ID: 9916657
    [Abstract] [Full Text] [Related]

  • 4. Lipase supplementation therapy: standards, alternatives, and perspectives.
    Layer P, Keller J.
    Pancreas; 2003 Jan; 26(1):1-7. PubMed ID: 12499909
    [Abstract] [Full Text] [Related]

  • 5. Pancreatic enzyme pharmacotherapy.
    Ferrone M, Raimondo M, Scolapio JS.
    Pharmacotherapy; 2007 Jun; 27(6):910-20. PubMed ID: 17542772
    [Abstract] [Full Text] [Related]

  • 6. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency: when is it indicated, what is the goal and how to do it?
    Domínguez-Muñoz JE.
    Adv Med Sci; 2011 Jun; 56(1):1-5. PubMed ID: 21450558
    [Abstract] [Full Text] [Related]

  • 7. Yarrowia lipolytica Lipase 2 Is Stable and Highly Active in Test Meals and Increases Fat Absorption in an Animal Model of Pancreatic Exocrine Insufficiency.
    Aloulou A, Schué M, Puccinelli D, Milano S, Delchambre C, Leblond Y, Laugier R, Carrière F.
    Gastroenterology; 2015 Dec; 149(7):1910-1919.e5. PubMed ID: 26327131
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Maldigestion from pancreatic exocrine insufficiency.
    Pongprasobchai S.
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():99-102. PubMed ID: 24251713
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of oral pancreatic enzyme therapy for the treatment of fat malabsorption in HIV-infected patients.
    Carroccio A, Guarino A, Zuin G, Verghi F, Berni Canani R, Fontana M, Bruzzese E, Montalto G, Notarbartolo A.
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1619-25. PubMed ID: 11564002
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Duodenal instillation of pancreatin does not abolish steatorrhea in patients with pancreatic insufficiency.
    Zerega J, Lerner S, Meyer JH.
    Dig Dis Sci; 1988 Oct; 33(10):1245-9. PubMed ID: 3168697
    [Abstract] [Full Text] [Related]

  • 14. Reduced intraluminal bile acid concentrations and fat maldigestion in pancreatic insufficiency: correction by treatment.
    Regan PT, Malagelada JR, Dimagno EP, Go VL.
    Gastroenterology; 1979 Aug; 77(2):285-9. PubMed ID: 447041
    [Abstract] [Full Text] [Related]

  • 15. Fate of pancreatic enzymes in the human intestinal lumen in health and pancreatic insufficiency.
    Layer P, Gröger G.
    Digestion; 1993 Aug; 54 Suppl 2():10-4. PubMed ID: 7693530
    [Abstract] [Full Text] [Related]

  • 16. New methods for assessment of enzyme activity: do they help to optimize enzyme treatment?
    Adler G, Mundlos S, Kühnelt P, Dreyer E.
    Digestion; 1993 Aug; 54 Suppl 2():3-9. PubMed ID: 7693531
    [Abstract] [Full Text] [Related]

  • 17. Correction of malnutrition and maldigestion with enzyme supplementation in patients with surgical suppression of exocrine pancreatic function.
    Braga M, Cristallo M, De Franchis R, Mangiagalli A, Agape D, Primignani M, Di Carlo V.
    Surg Gynecol Obstet; 1988 Dec; 167(6):485-92. PubMed ID: 3187872
    [Abstract] [Full Text] [Related]

  • 18. Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients.
    Gan KH, Heijerman HG, Geus WP, Bakker W, Lamers CB.
    Aliment Pharmacol Ther; 1994 Dec; 8(6):603-7. PubMed ID: 7696449
    [Abstract] [Full Text] [Related]

  • 19. Bile acid malabsorption or disturbed intestinal permeability in patients treated with enzyme substitution for exocrine pancreatic insufficiency is not caused by bacterial overgrowth.
    Madsen JL, Graff J, Philipsen EK, Scharff O, Rumessen JJ.
    Pancreas; 2003 Mar; 26(2):130-3. PubMed ID: 12604909
    [Abstract] [Full Text] [Related]

  • 20. Acid resistant lipase as replacement therapy in chronic pancreatic exocrine insufficiency: a study in dogs.
    Griffin SM, Alderson D, Farndon JR.
    Gut; 1989 Jul; 30(7):1012-5. PubMed ID: 2759481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.